atazanavir sulfate has been researched along with Biliary Tract Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casari, S; Castelli, F; Festa, E; Izzo, I; Lanza, P; Odolini, S; Vavassori, A; Zaltron, S | 1 |
| Calvez, V; Courbon, E; Katlama, C; Laylavoix, F; Le Beller, C; Peytavin, G; Soulié, C | 1 |
2 other study(ies) available for atazanavir sulfate and Biliary Tract Diseases
| Article | Year |
|---|---|
[Biliary and kidney lithiasis during treatment with daclatasvir/sofosbuvir/ribavirin and atazanavir/ritonavir + abacavir/lamivudine in an HIV/HCV genotype 4-infected patient: a case report.]
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Atazanavir Sulfate; Biliary Tract Diseases; Carbamates; Coinfection; Dideoxynucleosides; Drug Combinations; Drug Interactions; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Imidazoles; Kidney Calculi; Lamivudine; Lithiasis; Male; Pyrrolidines; Ribavirin; Ritonavir; Sofosbuvir; Valine | 2017 |
Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient.
Topics: Anti-HIV Agents; Atazanavir Sulfate; Biliary Tract Diseases; HIV Infections; Humans; Lithiasis; Male; Middle Aged; Oligopeptides; Pyridines | 2012 |